This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rubins, J B Articles by Niewoehner, D E Search for Related Content PubMed PubMed Citation Articles by Rubins, J B Articles by Niewoehner, D E

 Previous Article  |  Next Article 

Infection and Immunity, September 1994, p. 3829-3836, Vol. 62, No. 9
0019-9567/1994/$04.00+0     DOI:

research-article

Pneumolysin activates phospholipase A in pulmonary artery endothelial cells.

Department of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota.

ABSTRACT

Pneumolysin has been identified as a virulence factor in Streptococcus pneumoniae disease. In addition to producing tissue injury through its cytolytic effect, pneumolysin might injure tissues indirectly by eliciting an inflammatory response. We demonstrate for the first time that pneumolysin is a rapid and potent activator of cellular phospholipase A in bovine pulmonary artery endothelial cells. In contrast to other toxin-activated phospholipases, pneumolysin-stimulated phospholipase A showed no substrate specificity among major cellular membrane phospholipids. Phospholipase A activation required the formation of functional transmembrane pores by pneumolysin rather than membrane lipid perturbation. Pneumolysin stimulation of phospholipase A was calcium dependent; however, pneumolysin did not appear to function simply as a calcium ionophore. Pneumolysin was capable of stimulating purified bee and snake venom phospholipase A2s against a phospholipid substrate isolated from endothelial cells. Thus, pneumolysin stimulates cellular phospholipase A and the resulting products might further injure tissues by direct cytolytic effect or by evoking inflammatory responses.

This article has been cited by other articles:

• Spreer, A., Kerstan, H., Bottcher, T., Gerber, J., Siemer, A., Zysk, G., Mitchell, T. J., Eiffert, H., Nau, R. (2003). Reduced Release of Pneumolysin by Streptococcus pneumoniae In Vitro and In Vivo after Treatment with Nonbacteriolytic Antibiotics in Comparison to Ceftriaxone. Antimicrob. Agents Chemother. 47: 2649-2654 [Abstract] [Full Text]  
• Kadioglu, A., Taylor, S., Iannelli, F., Pozzi, G., Mitchell, T. J., Andrew, P. W. (2002). Upper and Lower Respiratory Tract Infection by Streptococcus pneumoniae Is Affected by Pneumolysin Deficiency and Differences in Capsule Type. Infect. Immun. 70: 2886-2890 [Abstract] [Full Text]  
• Baba, H., Kawamura, I., Kohda, C., Nomura, T., Ito, Y., Kimoto, T., Watanabe, I., Ichiyama, S., Mitsuyama, M. (2002). Induction of Gamma Interferon and Nitric Oxide by Truncated Pneumolysin That Lacks Pore-Forming Activity. Infect. Immun. 70: 107-113 [Abstract] [Full Text]  
• Alcantara, R. B., Preheim, L. C., Gentry-Nielsen, M. J. (2001). Pneumolysin-Induced Complement Depletion during Experimental Pneumococcal Bacteremia. Infect. Immun. 69: 3569-3575 [Abstract] [Full Text]  
• Cockeran, R., Steel, H. C., Mitchell, T. J., Feldman, C., Anderson, R. (2001). Pneumolysin Potentiates Production of Prostaglandin E2 and Leukotriene B4 by Human Neutrophils. Infect. Immun. 69: 3494-3496 [Abstract] [Full Text]  
• GILLESPIE, S.H., BALAKRISHNAN, I. (2000). Pathogenesis of pneumococcal infection. J Med Microbiol 49: 1057-1067 [Abstract] [Full Text]  
• Kadioglu, A., Gingles, N. A., Grattan, K., Kerr, A., Mitchell, T. J., Andrew, P. W. (2000). Host Cellular Immune Response to Pneumococcal Lung Infection in Mice. Infect. Immun. 68: 492-501 [Abstract] [Full Text]